ArticleInternational journal of clinical pharmacy2025
Clinical Pharmacist and Clinical Nurse Specialist led medicine optimisation and medication adherence via eArly identifiCation advanCed gEriatric aSsesSment (ACCESS) tool in Senior Adult Oncology Programme (SAOP).
Article in International journal of clinical pharmacy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Correction: European Society of Clinical Pharmacy: 5 steps of medication safety-medication without harm, where are we now?International journal of clinical pharmacy · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundComprehensive geriatric assessment evaluates key health domains for older adults, focusing on medicine optimisation and medication adherence to improve tolerability and quality of life for older adults on systematic anticancer therapy. The Royal Marsden (RM) Senior Adult Oncology Programme (SAOP) provides multidisciplinary geriatric assessment and interventions for patients ≥ 70 undergoing systematic anticancer therapy.
aimWe designed an ACCESS (eArly identifiCation advanCed gEriatric aSsesSment) tool to enhance efficiency of SAOP outpatient clinics by facilitating geriatric assessment including medications, nutrition, social support, mood, and functional assessments.
settingSAOP at RM NHS Foundation Trust, London, UK. DEVELOPMENT: Developed by SAOP pharmacist and clinical nurse specialist with input from SAOP multidisciplinary team, the ACCESS tool includes medication review patient counselling deprescribing, and comorbidity management, aligning with the Royal Pharmaceutical Society Advanced Pharmacy Framework. IMPLEMENTATION: From January to December 2022, ACCESS was implemented in three steps: screening with Senior Adult Oncology Programme v 3 (SAOP3) questionnaire, remote consultation based on results, and medication review and patient counselling for complex medication needs, enhancing patient engagement and treatment understanding. EVALUATION: The practice was audited through the implementation process. Quantitative data from staff and 100 patients who were users of the SAOP service and ACCESS tool revealed higher medication adherence, improved identification of inappropriate medications, and enhanced confidence in managing complex geriatric oncology cases.
conclusionThe ACCESS tool, led by clinical pharmacist and clinical nurse specialist has improved outpatient clinic efficiency, patient satisfaction, and healthcare coordination. It allows personalised follow-up plans for older adults with complex health issues on anticancer therapy. Regular multidisciplinary team meetings and digital health records enhance care coordination and decision-making for older adults with cancer.
Indexed as
Identifiers
39928067What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.